Eugene Ozhinsky1, Vasant A. Salgaonkar2, Chris J. Diederich2, and Viola Rieke1
1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States, 2Radiation Oncology, University of California San Francisco, San Francisco, CA, United States
Synopsis
We have developed and evaluated a real-time MR thermometry-guided
system for acoustic power output and beam pattern control for prostate hyperthermia
therapy. It was designed to be integrated with a commercial focused ultrasound ablation
system and supports real-time ultrasound phase pattern switching and MR
thermometry for monitoring and automated power adjustment.Introduction
Hyperthermia (HT, 40-45°C, 30-60 min) has been combined
successfully with several cancer treatment modalities, such as radiation,
chemotherapy and drug delivery (1,2) to enhance treatment efficacy. Clinical
studies have demonstrated feasibility of safe application of prostate
hyperthermia with endorectal ultrasound applicators (3). The goal of this project was to implement an MR thermometry-guided
hyperthermia that allowed to change both shape and acoustic power of the beam
in real time.
Methods
The real-time thermometry application (fig. 1) was developed for the RTHawk real-time MRI system (HeartVista, Inc., Menlo Park, CA), connected to a 3T MR scanner (GE Healthcare, Waukesha, WI) and the ExAblate 2100 prostate array (InSightec, Haifa, Israel). The application included an SPGR pulse sequence (TE = 13.4 ms, FOV = 28-32 cm, 3 s/slice), a real-time PRFS thermometry reconstruction pipeline and a custom interface for data visualization and prescription. The system provided for interleaved simultaneous acquisition of multiple slices at different orientations. Temperature measurement was implemented using user-adjustable elliptical ROIs.
The beam controller module was implemented for the RTHawk MR Thermometry application (fig. 1,2). It featured a proportional integral feedback controller for automated beam power adjustment and an ability to switch between up to 4 transducer phasing patters (single focus at 60 mm depth, simultaneous 4 point focusing with the focal distance of 60 mm and spread of 5, 10 and 15 mm).
To interface with vendor ultrasound control software, a Control Proxy Server application was developed. It accepted connections from the beam controller module over the local area network and translated commands into calls of the vendor-provided software interface.
The system was evaluated in experiments with a tissue
mimicking phantom for prolonged exposures at max. electrical power of 10 W.
Results
and
Discussion
Fig. 3 (d-f) shows MR thermometry images during heating with
the three phasing patterns. We were able to achieve the heating patterns that
closely resembled the simulated beam shapes (fig. 3, a-c). Changing the spread
of focal points in real-time allowed to adjust the beam shape and could be used
to achieve the desired heating pattern for a particular patient anatomy and
tissue thermal conductivity.
One limitation of the current technique is a limited range
of beam depth due to the small number of discrete phase values, supported by
the phased array transducer. Future work will focus on implementing phased
patterns for different treatment scenarios (4) and in-vivo validation.
In conclusion, we have implemented a real-time MR
thermometry-guided ultrasound beam control system for long duration prostate
hyperthermia therapy and validated it in phantom experiments.
Acknowledgements
We would like to thank Benny Assif, Alex
Kavushansky, Yerucham Shapira (Insightec, Inc.) for technical assistance with
this project. This work was supported by Focused Ultrasound Foundation, NIH
R01CA12276, R01CA111981, R00HL097030, UCSF-RAP.References
1.
Wust P, Hildebrandt B, Sreenivasa G, Rau B,
Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment
of cancer. The Lancet Oncology 2002;3(8):487-497.
2.
Ponce AM, Vujaskovic Z, Yuan F, Needham D,
Dewhirst MW. Hyperthermia mediated liposomal drug delivery. International
journal of hyperthermia : the official journal of European Society for
Hyperthermic Oncology, North American Hyperthermia Group 2006;22(3):205-213.
3.
Hutchinson E, Dahleh M, Hynynen K. The
feasibility of MRI feedback control for intracavitary phased array hyperthermia
treatments. International journal of hyperthermia : the official journal of
European Society for Hyperthermic Oncology, North American Hyperthermia Group
1998;14(1):39-56.
4.
Salgaonkar VA, Prakash P, Rieke V, Ozhinsky E,
Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. Model-based feasibility
assessment and evaluation of prostate hyperthermia with a commercial MR-guided
endorectal HIFU ablation array. Med Phys 2014;41(3):033301.